Caption Management, LLC Pliant Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.52 - $14.35 $1.52 Million - $2.07 Million
-144,500 Reduced 82.81%
30,000 $336,000
Q2 2024

Aug 14, 2024
BUY
$10.58 - $15.61 $312,110 - $460,495
29,500 Added 20.34%
174,500 $1.88 Million
Q1 2024

May 15, 2024
BUY
$14.14 - $19.59 $1.63 Million - $2.25 Million
115,000 Added 383.33%
145,000 $2.16 Million
Q2 2023

Aug 14, 2023
BUY
$18.12 - $30.56 $543,600 - $916,800
30,000 New
30,000 $543,000
Q2 2022

Aug 15, 2022
BUY
$4.11 - $8.75 $205,500 - $437,500
50,000 New
50,000 $400,000

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email